Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis
CONCLUSIONS: GLP-1 RAs and SGLT-2 inhibitors seem to be the most efficacious glucose-lowering drugs for liver steatosis in patients with T2D. Assessment of their efficacy on NAFLD in patients irrespective of presence of T2D is encouraged.PMID:37770761 | DOI:10.1007/s42000-023-00493-z (Source: Hormones)
Source: Hormones - September 28, 2023 Category: Endocrinology Authors: Konstantinos Malandris Stylianos Papandreou Ioannis Avgerinos Thomas Karagiannis Paschalis Paschos Theodoros Michailidis Aris Liakos Eleni Bekiari Emmanouil Sinakos Apostolos Tsapas Source Type: research
Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management
Hormones (Athens). 2023 Sep 27. doi: 10.1007/s42000-023-00491-1. Online ahead of print.ABSTRACTThe widespread use of glucocorticoids (GCs) contributes to the effective management of several diseases and conditions. However, it comes at a price in the case of the bones causing glucocorticoid-induced osteoporosis (GIOP), the most common cause of secondary osteoporosis and fractures. Several scientific societies have issued comprehensive guidelines on the optimal management of patients receiving GCs with the aim of providing answers to three fundamental questions, namely, whom to treat, when to treat, and how to treat. Both c...
Source: Hormones - September 27, 2023 Category: Endocrinology Authors: Eleni Anastasilaki Julien Paccou Konstantinos Gkastaris Athanasios D Anastasilakis Source Type: research
Machine learning-based prediction of risk factors for abnormal glycemic control in diabetic cancer patients receiving nutrition support: a case-control study
CONCLUSION: The use of SU and BUN level > 20 mg/dL increased the risk of hypoglycemia, whereas an initial blood glucose level ≥ 182.5 mg/dL, a supplied actual energy intake/ TEE ≥ 120%, and the use of DPP-4 inhibitors increased the risk of hyperglycemia.PMID:37755659 | DOI:10.1007/s42000-023-00492-0 (Source: Hormones)
Source: Hormones - September 27, 2023 Category: Endocrinology Authors: Jee Yun Kim Ji Min Han Bona Yun Jeong Yee Hye Sun Gwak Source Type: research
Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management
Hormones (Athens). 2023 Sep 27. doi: 10.1007/s42000-023-00491-1. Online ahead of print.ABSTRACTThe widespread use of glucocorticoids (GCs) contributes to the effective management of several diseases and conditions. However, it comes at a price in the case of the bones causing glucocorticoid-induced osteoporosis (GIOP), the most common cause of secondary osteoporosis and fractures. Several scientific societies have issued comprehensive guidelines on the optimal management of patients receiving GCs with the aim of providing answers to three fundamental questions, namely, whom to treat, when to treat, and how to treat. Both c...
Source: Hormones - September 27, 2023 Category: Endocrinology Authors: Eleni Anastasilaki Julien Paccou Konstantinos Gkastaris Athanasios D Anastasilakis Source Type: research
Machine learning-based prediction of risk factors for abnormal glycemic control in diabetic cancer patients receiving nutrition support: a case-control study
CONCLUSION: The use of SU and BUN level > 20 mg/dL increased the risk of hypoglycemia, whereas an initial blood glucose level ≥ 182.5 mg/dL, a supplied actual energy intake/ TEE ≥ 120%, and the use of DPP-4 inhibitors increased the risk of hyperglycemia.PMID:37755659 | DOI:10.1007/s42000-023-00492-0 (Source: Hormones)
Source: Hormones - September 27, 2023 Category: Endocrinology Authors: Jee Yun Kim Ji Min Han Bona Yun Jeong Yee Hye Sun Gwak Source Type: research
Flash glucose monitoring system in gestational diabetes: a study of accuracy and usability
CONCLUSION: FGMS showed good performance in GD regarding accuracy and usability. Larger studies are needed to corroborate our results, verify the analytical accuracy of above-target values as this glucose range might lead to initiation or adjustment of pharmacological therapy, and ultimately establish definitive recommendations regarding prescription of FGMS for GD patients.PMID:37740861 | DOI:10.1007/s42000-023-00485-z (Source: Hormones)
Source: Hormones - September 23, 2023 Category: Endocrinology Authors: Sara Campos Lopes Ana Isabel Brito Mariana Barbosa Ana Catarina Matos Maria Lopes Pereira Ana Margarida Monteiro Vera Fernandes Source Type: research
Alterations in neuroendocrine axes in brain-dead patients
CONCLUSION: This study supports the hypothesis that the anterior pituitary gland continues to function in the brain-dead state.PMID:37736855 | DOI:10.1007/s42000-023-00489-9 (Source: Hormones)
Source: Hormones - September 22, 2023 Category: Endocrinology Authors: T ürkay Akbaş Ayhan Öztürk Source Type: research
A roadmap to medical nutrition therapy in type 2 diabetes
Hormones (Athens). 2023 Sep 21. doi: 10.1007/s42000-023-00483-1. Online ahead of print.NO ABSTRACTPMID:37733216 | DOI:10.1007/s42000-023-00483-1 (Source: Hormones)
Source: Hormones - September 21, 2023 Category: Endocrinology Authors: Almog Shalit Stavroula A Paschou Theodora Psaltopoulou Source Type: research
Hepatokines: the missing link in the development of insulin resistance and hyperandrogenism in PCOS?
Hormones (Athens). 2023 Sep 14. doi: 10.1007/s42000-023-00487-x. Online ahead of print.ABSTRACTThe liver plays a critical role in several metabolic pathways, including the regulation of glucose and lipid metabolism. Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver disease worldwide, is closely associated with insulin resistance (IR) and metabolic syndrome (MetS). Hepatokines, newly discovered proteins secreted by hepatocytes, have been linked to the induction of these metabolic dysregulations. Polycystic ovary syndrome (PCOS), the most common endocrine disorder in women of reproductive age, has been...
Source: Hormones - September 13, 2023 Category: Endocrinology Authors: Katerina Stefanaki Ioannis Ilias Stavroula A Paschou Dimitrios S Karagiannakis Source Type: research
Obstructive sleep apnea and vitamin D: an updated systematic review and meta-analysis
CONCLUSION: Patients with OSA have lower serum 25-OHD levels with a higher prevalence of vitamin D deficiency, regardless of age or BMI, pointing to an independent association between vitamin D and OSA.PMID:37704922 | DOI:10.1007/s42000-023-00481-3 (Source: Hormones)
Source: Hormones - September 13, 2023 Category: Endocrinology Authors: Huai Heng Loh Quan Hziung Lim Waye Hann Kang Anne Yee Mei Ching Yong Norlela Sukor Source Type: research
Hepatokines: the missing link in the development of insulin resistance and hyperandrogenism in PCOS?
Hormones (Athens). 2023 Sep 14. doi: 10.1007/s42000-023-00487-x. Online ahead of print.ABSTRACTThe liver plays a critical role in several metabolic pathways, including the regulation of glucose and lipid metabolism. Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver disease worldwide, is closely associated with insulin resistance (IR) and metabolic syndrome (MetS). Hepatokines, newly discovered proteins secreted by hepatocytes, have been linked to the induction of these metabolic dysregulations. Polycystic ovary syndrome (PCOS), the most common endocrine disorder in women of reproductive age, has been...
Source: Hormones - September 13, 2023 Category: Endocrinology Authors: Katerina Stefanaki Ioannis Ilias Stavroula A Paschou Dimitrios S Karagiannakis Source Type: research
